Clinical TrialChronic PainKetamineCompleted

Neuromodulation to Facilitate the Effect of Ketamine

Retrospective case-control study (n=35) evaluating concurrent TMS with ketamine infusion in patients with chronic emotional and/or somatic pain.

Target Enrollment
35 participants
Study Type
Phase NA observational
Design
Non-randomized

Detailed Description

Retrospective case-control study of 35 patients receiving co-administration of transcranial magnetic stimulation and ketamine infusion in a clinical setting to assess whether neuromodulation enhances therapeutic benefit.

Primary population comprised patients in a single clinic with chronic emotional and/or somatic pain who are treatment-resistant; outcomes and analyses derived from clinical records.

Study Arms & Interventions

TMS + ketamine

experimental

Co-administration of transcranial magnetic stimulation with ketamine infusion for chronic emotional and/or somatic pain (case-control, retrospective).

Interventions

  • Ketamine
    via IV• as clinically indicated

    Ketamine infusion administered concurrently with TMS (dose per clinical protocol, not specified).

Participants

Ages
18 – 99
Sexes
Male & Female

Inclusion Criteria

  • Inclusion Criteria:
  • Chronically ill
  • Treatment-resistant

Exclusion Criteria

  • Exclusion Criteria:
  • Active psychosis

Study Details

  • Status
    Completed
  • Phase
    Phase NA
  • Type
    observational
  • Design
    Non-randomized
  • Target Enrollment35 participants
  • Timeline
    Start: 2011-01-01
    End: 2012-01-11
  • Compound
    Ketamine
  • Topic
    Chronic Pain

Locations

The Neuroscience Center — Deerfield, Illinois, United States

Your Library